ARCHIVES

Clinical Trials Approved By NCI CTEP Last Month

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

Anil Potti Joins Myrtle Beach Private Practice.

June 3, 2011

ORI Must Release Documents In Fisher Case, Judge Rules

September 8, 1995

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

Group Lobby To Add $200 Mil. To Cancer Budget

April 26, 1991